Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Gyre Therapeutics Inc | GYRE | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
15.63 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
13/5/2024 | 15:07 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/5/2024 | 15:10 | GLOBE | Gyre Therapeutics Reports First Quarter 2024 Financial.. |
09/5/2024 | 15:05 | EDGAR2 | Form 8-K - Current report |
08/5/2024 | 07:00 | EDGAR2 | Form 8-K - Current report |
26/3/2024 | 05:00 | GLOBE | Gyre Therapeutics Reports Full Year 2023 Financial Results.. |
21/3/2024 | 06:00 | GLOBE | Gyre Therapeutics Expands Board of Directors with.. |
15/12/2023 | 08:04 | PRNUS | Totus Medicines Announces Appointment of Nassim Usman,.. |
13/11/2023 | 06:00 | GLOBE | Gyre Therapeutics Presents Poster at the American.. |
02/11/2023 | 16:00 | EDGAR2 | Form 8-K - Current report |
01/11/2023 | 16:18 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
01/11/2023 | 15:58 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |